Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy

Breast Cancer Research and Treatment

Volumn 115, Issue 3, 2009, Pages 601-608

  Milano, Michael T ^a   Zhang, Hong ^a   Metcalfe, Su K ^a   Muhs, Ann G ^a   Okunieff, Paul ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Oligometastases; Stereotactic body radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 67349257418     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0157-4     Document Type: Article

References (27)

1. Rubin P, Green J (1968) Solitary metastases. Charles C. Thomas, Springfield, IL
2. L Milas N Hunter HR Withers 1976 Concomitant immunity to pulmonary metastases of a murine fibrosarcoma: influence of removal of primary tumor by radiation or surgery, of active specific immunization and treatment with Corynebacterium granulosum Int J Radiat Oncol Biol Phys 1 1171 1178 (Pubitemid 8006182)
3. Rosenberg SA (1987) Surgical treatment of metastatic cancer. Lippincott Williams & Wilkins, Philadelphia, PA
4. S Hellman RR Weichselbaum 1995 Oligometastases J Clin Oncol 13 8 10
5. S Hellman 1994 Karnofsky memorial lecture. Natural history of small breast cancers J Clin Oncol 12 2229 2234
6. B Fisher 1980 Laboratory and clinical research in breast cancer-a personal adventure: the David A. Karnofsky memorial lecture Cancer Res 40 3863 3874 (Pubitemid 11234057)
7. B Fisher C Redmond ER Fisher 1980 The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology-an overview of findings Cancer 46 1009 1025 10.1002/1097-0142(19800815) 46:4<1009::AID-CNCR2820461326>3.0.CO;2-H (Pubitemid 10027061)
8. N Mehta AM Mauer S Hellman 2004 Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment Int J Oncol 25 1677 1683
9. SE Singletary G Walsh JN Vauthey 2003 A role for curative surgery in the treatment of selected patients with metastatic breast cancer Oncologist 8 241 251 10.1634/theoncologist.8-3-241
10. CR Tait A Waterworth J Loncaster 2005 The oligometastatic state in breast cancer: hypothesis or reality Breast 14 87 93 10.1016/j.breast.2004.10.003
11. M Carey Sampson A Katz LS Constine 2006 Stereotactic body radiation therapy for extracranial oligometastases: does the sword have a double edge? Semin Radiat Oncol 16 67 76 10.1016/j.semradonc.2005.12.002
12. RD Timmerman BD Kavanagh LC Cho 2007 Stereotactic body radiation therapy in multiple organ sites J Clin Oncol 25 947 952 10.1200/JCO.2006.09.7469
13. BD Kavanagh RC McGarry RD Timmerman 2006 Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases Semin Radiat Oncol 16 77 84 10.1016/j.semradonc.2005.12.003
14. AW Katz M Carey-Sampson AG Muhs 2006 Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases Int J Radiat Oncol Biol Phys 67 793 798 10.1016/j.ijrobp.2006.10.025
15. P Okunieff AL Petersen A Philip 2006 Stereotactic Body Radiation Therapy (SBRT) for lung metastases Acta Oncol 45 808 817 10.1080/02841860600908954
16. Milano MT, Katz AW, Schell MC et al (2008) Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys (in press)
17. MT Milano AW Katz AG Muhs 2008 A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions Cancer 112 650 658 10.1002/cncr.23209
18. D Singh WS Yi RA Brasacchio 2004 Is there a favorable subset of patients with prostate cancer who develop oligometastases? Int J Radiat Oncol Biol Phys 58 3 10 10.1016/S0360-3016(03)01442-1
19. WG O'Dell MC Schell D Reynolds 2002 Dose broadening due to target position variability during fractionated breath-held radiation therapy Med Phys 29 1430 1437 10.1118/1.1485977
20. P Therasse SG Arbuck EA Eisenhauer 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 10.1093/jnci/92.3.205
21. E Rivera FA Holmes AU Buzdar 2002 Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast cancer with no evidence of disease Breast J 8 2 9 10.1046/j.1524-4741.2002.08002.x
22. AU Buzdar GR Blumenschein ED Montague 1984 Combined modality approach in breast cancer with isolated or multiple metastases Am J Clin Oncol 7 45 50 10.1097/00000421-198402000-00006 (Pubitemid 14158430)
23. FA Holmes AU Buzdar S-W Kau 1994 Combined-modality approach for patients with isolated recurrences of breast cancer (IV-NED): the M.D. Anderson experience Breast Dis 7 7 20 (Pubitemid 24010824)
24. GR Blumenschein A DiStefano J Caderao 1997 Multimodality therapy for locally advanced and limited stage IV breast cancer: the impact of effective non-cross-resistance late-consolidation chemotherapy Clin Cancer Res 3 2633 2637 (Pubitemid 28133119)
25. Y Nieto PJ Cagnoni EJ Shpall 1999 Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease Clin Cancer Res 5 1731 1737 (Pubitemid 29334453)
26. Y Nieto S Nawaz RB Jones 2002 Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer J Clin Oncol 20 707 718 10.1200/JCO.20.3.707
27. EO Hanrahan KR Broglio AU Buzdar 2005 Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors Cancer 104 1158 1171 10.1002/cncr.21305